万嘉集团发布中期业绩,股东应占亏损71.2万港元

Core Points - The company reported a revenue of HKD 85.706 million for the six months ending September 30, 2025, representing a year-on-year increase of 2.4% [1] - The company recorded a loss attributable to shareholders of HKD 0.712 million, compared to a profit of HKD 1.256 million in the same period last year [1] - The basic loss per share was HKD 0.127 [1] - The increase in revenue was driven by the growth in the blood dialysis business [1]